Home » Topics » Ocular, BioWorld Science

Ocular, BioWorld Science
RSS

Clinical section of Vitrase NDA submitted

Oct. 14, 2002

INS-365, a mucin stimulant, effective in a rabbit model of dry eye syndrome

Oct. 7, 2002

Humanized anti-VEGF antibody fragment proves effective in wet AMD

Oct. 4, 2002

Phase I/II results for INS-37217 in rhegmatogenous retinal detachment

Oct. 4, 2002

Twelve-month data show efficacy of anecortave acetate in wet AMD

Oct. 2, 2002

ISV-401 safe and effective in acute bacterial conjunctivitis

Oct. 1, 2002

New phase III study for anecortave acetate in AMD

Sep. 5, 2002

Compounds for glaucoma and ocular hypertension with improved profile over natural prostaglandins

Sep. 4, 2002

E.U. approval for Visudyne

Sep. 2, 2002

Subanalysis of SnET2 phase III data

Aug. 29, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...